Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 4 Results

Title
Intervention Indication Therapeutic Area Year Actions
Tislelizumab in combination with Paclitaxel, Cisplatin, and Radiotherapy for Oesophageal cancer Cisplatin (Platinol) , Paclitaxel (Taxol; paclitaxel albumin) , Tislelizumab (BGB-A317; BGBA-317) Squamous cell carcinoma (SCC) Head and Neck Cancer 2022 View  |  Download
Leukocyte interleukin with cyclophosphamide, indomethacin, and zinc for neoadjuvant therapy of squamous cell carcinoma of the head and neck Cyclophosphamide (Procytox; cyclophosphamide monohydrate) , Leukocyte interleukin (CS001P3; Multikine) Head and neck cancer , Squamous cell carcinoma (SCC) Head and Neck Cancer 2023 View  |  Download
Lenvatinib with pembrolizumab for the treatment of squamous cell carcinoma of the head and neck Lenvatinib (Kisplyx; E7080; lenvatinib mesilate) , Pembrolizumab (Keytruda; MK-3475) Head and neck cancer , Squamous cell carcinoma (SCC) Head and Neck Cancer 2022 View  |  Download
Cemiplimab for advanced cutaneous squamous cell Cemiplimab (Libtayo; REGN2810) Squamous cell carcinoma (SCC) Skin Cancer 2017 View  |  Download
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications